Class I eiiiaaoeiiiue lāʻau o JYMed ua i holomua loa ai kākou, Laipushutai ua manaoia e lilo i ka laina mua o UC ai '.

Ma June 29, 2017, i ka ulu ana o Laipushutai, ke papa aʻu eiiiaaoeiiiue lapaau ana me ka Free kūpono 'ana o JYMed a me Guangzhou Linkhealth Lapaʻau Technology Co., Ltd., ua i holomua loa ai kākou. I ka lāʻau o IND hoike ana'ku i ua aeia lakou e ka CFDA.

JYMed a Guangzhou Linkhealth Lapaʻau Technology Co., Ltd. hiki i ke alu like 'aelike i ka 2016 a hiki i Kāʻeokūlani, hoʻomōhala i kēia huahana ma Kina. O? Ueo Ua ana POC lapaʻau haʻawina i loko o ka eu, a loaʻa maikai maluhia a me ke kala ana i holo 'awelika. Ua ka FDA, a me ka EMA hooiaio i keia? Ueo hiki e pili no ka lapaau ana i ka I / II laina, a me ka makakoho e e hāʻawi ai i ke kokua a me ka hana ana o nā mea maʻi me ka lōpū ulcerative colitis ma ka pane lapaʻau hookolokolo o CFDA.

Ulcerative colitis (UC) mea he maʻi, ai '-i ho'ākāka' hoʻoʻino mai e ia lŘlŘ ma ka rectum a me ka AeXIeAaOIePEAaI. E like me ka 'ikepili helu, ka mea hiki wale mai uku o UC mea 1,2 i 20,3 hihia / 100.000 kanaka no ka makahiki, a me ka prevalence o UC mea 7,6 i 246,0 hihia / 10,000 kanaka no ka makahiki. Ka mea hiki wale mai o UC mea oi, he pono ole i ka opiopio makua. Na UC market, ua nui ka unahiʻole, a me ke koi no ka ai ', a e hoʻomau i ka malama i ka kiʻekiʻe ulu nā mea kū i loko o ka wā e hiki mai. No laila, ma kahi lōʻihi, UC mua-laina lāʻau uaʻano nui ka nānā 'ana ma luna o mesalazine a me hormones, a me ka lua o ka-laina ai' nā immunosuppressants a me liluwelo monoclonal nā mea'aʻaʻa. Mesalazine i ke kuai ana ka leo o ka 1 ieeeea ma Kina, a US $ 2 ieeeea? I loko o ka United States i ka 2015. Laipushutai i ka maikaʻi pane i UC symptoms, a me ka mea i pakele ma mua o kaʻikena mua-laina ai '. He i He maikai kuai lanakila, a ua manaoia e lilo i mua-laina UC lāʻau.

333661

 


Post manawa: Mar-02-2019
WhatsApp Online eʻauʻau kai!